Anchala Kumari

Employment

• National Institute of Pharmaceutical Education and Research
  2024 - Present
• Arontier Senior Scientist
  2022 - 2023
• Indian Council of Medical Research Scientist C
  2022 - 2022
• Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Scientist
  2021 - 2022
• TERI School of Advanced Studies PhD Scholar
  2016 - 2020
• Jawaharlal Nehru University Senior Research Fellow/PhD Scholar
  2015 - 2020
• International Centre For Genetic Engineering and Biotechnology Research Fellow
  2013 - 2015

Education

• Birla Institute of Technology M.Sc
  2010 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• Unmasking the role of tumor microenvironment in the advanced stage of cancer treatment to mitigate risks during chemotherapy
  Biochemical Pharmacology 2026 DOI: 10.1016/J.BCP.2026.117754
  +Save
• siRNA-based Therapeutics in Hormone-driven Cancers: Advancements and benefits over conventional treatments
  International Journal of Pharmaceutics 2025 DOI: 10.1016/j.ijpharm.2025.125463
  +Save
• Small molecule MET kinase inhibitors: Evolution, rational design, and early clinical knowledge
  Life Sciences 2025 DOI: 10.1016/j.lfs.2025.124079
  +Save
• Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h‐BRCA1
  Proteins: Structure, Function, and Bioinformatics 2024 DOI: 10.1002/prot.26638
  +Save
• Variant of uncertain significance Arg866Cys enhances disorderedness of h-BRCA1 (759-1064) region
  The International Journal of Biochemistry & Cell Biology 2024 DOI: 10.1016/j.biocel.2024.106527
  +Save
• Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)
  Rsc Advances 2022 DOI: 10.1039/d2ra05061g
  +Save
• Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG) (RSC Adv. (2022) 12 (29469-29481) DOI: 10.1039/D2RA05061G)
  Rsc Advances 2022 DOI: 10.1039/d2ra90131e
  +Save
• Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins
  Journal of Biomolecular Structure and Dynamics 2022 DOI: 10.1080/07391102.2021.1924265
  +Save
• 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus
  Bioorganic Chemistry 2021 DOI: 10.1016/j.bioorg.2021.105031
  +Save
• Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework
  Scientific Reports 2021 DOI: 10.1038/s41598-021-86986-6
  +Save